TITLE

New Report Goes Beyond Medicare Cards to Analyze Drug Information Across Several Sources; Nonprofit Calls on Medicare to Delay Start of Drug-Discount Cards Until More Stable and

PUB. DATE
May 2004
SOURCE
Ascribe Newswire: Medicine;5/21/2004, p77
SOURCE TYPE
Newswire
DOC. TYPE
Article
ABSTRACT
A California nonprofit will release a report on Friday comparing price information for 20 drugs commonly prescribed to Medicare beneficiaries, revealing that consumers who are not eligible for a $600 credit may be better off using existing sources instead of a new Medicare drug-discount card. Medicine for People in Need (Medpin), a program of the nonprofit Public Health Institute, Oakland, compared pricing information for 20 top brand-name and generic drugs using these sources. "We were disappointed to discover how difficult it is now for a California Medicare patient to make an informed decision about purchasing," says Kathryn Duke, program director for Medpin.
ACCESSION #
13223147

 

Related Articles

  • Prescription Drugs: Price Trends for Frequently Used Brand and Generic Drugs from 2000 through 2004: GAO-05-77.  // GAO Reports;9/15/2005, p1 

    Prescription drug spending has been the fastest growing segment of national health expenditures. As the federal government assumes greater financial responsibility for prescription drug expenditures with the introduction of Medicare part D, federal policymakers are increasingly concerned about...

  • Pharmacy to CMS: Medicaid rule is recipe for disaster. Paul, Reid // Drug Topics;1/22/2007, Vol. 151 Issue 2, p34 

    The article focuses on the proposed rule of the Centers for Medicare & Medicaid Services under the provisions of the Deficit Reduction Act of 2005 (DRA) concerning the five-year period Medicaid generic drug reimbursement. The DRA covers the modification of the formula for calculating federal...

  • Impact of an Annual Dollar Limit or "Cap" on Prescription Drug Benefits for Medicare Patients. Tseng, Chien-Wen; Brook, Robert; Keeler, Emmett; Mangione, Carol // JAMA: Journal of the American Medical Association;7/9/2003, Vol. 290 Issue 2, p222 

    Discusses the impact of an annual dollar limit or cap on prescription drug benefits for Medicare patients. Prescription benefit caps in the plan; Increase in the cost of prescription drugs since the enactment of Medicare; Lack of generic drug options; Out-of-pocket prescription costs.

  • Drug-price escalation is likely to slow. Toth, David // Fairfield County Business Journal;4/25/2005, Vol. 44 Issue 17, p25 

    The article reports that the Center for Medicare and Medicaid Services (CMS) has stated in a study that although prescription drug spending is at an all-time high, the growth may be slowing and that trend is likely to continue. The high cost of using a brand name medication when a generic brand...

  • Medicare, Medicaid spur generics prospects. Frederick, James // Drug Store News;9/25/2006, Vol. 28 Issue 12, p40 

    The article reports on the projected increase in sales of generic drugs triggered by the two biggest health care purchasers in the U.S. in 2007. To contain soaring costs of health care expenses, health care agencies are resorting to generic drugs to increase state savings by instituting...

  • GOVERNMENT DRUG POLICIES IN CANADA OFFER NO COST ADVANTAGE OVER US DRUG POLICIES.  // Canadian Journal of Dental Hygiene;Jan/Feb2008, Vol. 42 Issue 1, p39 

    The article reports on the results of a study entitled "The Cost Burden of Prescription Drug Spending in Canada and the U.S." The research found that Canadians spend roughly the same percentage of their incomes on prescription drugs as U.S. consumers. B. Skinner, director of Health...

  • Canadian price controls destroying market competition.  // PharmacoEconomics & Outcomes News;3/12/2005, Issue 473, p10 

    Reports on the impact of pharmaceutical price controls imposed by Canadian authorities on market competition. Effect of the pharmaceutical policy on healthcare spending in the country; Criticism against high prices of generic drugs in Canada compared with the U.S.; Average amount spent by...

  • Where Would We Be With No Generics? Coopman, Robert // Chain Drug Review;2/22/2016, Vol. 38 Issue 4, p67 

    The article reports on the increase in brand medication spending and the decline in costs for generic medications in the U.S. for 2015.

  • Medicare Prescription Drug Discount Card Program Could Save All Seniors Without Drug Coverage a Total of $1 Billion.  // Ascribe Newswire: Medicine;4/16/2004, p55 

    Medicare's prescription drug discount card program could save seniors without any other drug coverage an average of 17.4 percent in out-of-pocket costs, according to an article published today on the journal "Health Affairs" Web site. Juliette Cubanski, a Harvard University health policy...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics